MBS Item 18375 update

An update has been provided regarding MBS Item 18375, for intravesical botox in neurogenic patients.

This item has had the 85% rebate removed when done in a hospital or hospital equivalent setting. At present the descriptor does not have a (H) attached to it. This has been raised with the Department of Health and they have advised that this oversight will be rectified in the coming months with the (H) added to the descriptor.